IL2 and hydronephrosis: One treatment-related death occurred: a patient with baseline hydronephrosis tolerated chemotherapy and TIL infusion but deteriorated two days after the tenth IL-2 dose, dying of refractory metabolic acidosis with no clear anatomic cause at autopsy.